Beyond the Veil| Unimaginable as it seems, the outstanding news that scientists now have a vaginal microbe that significantly reduces HIV infections in women hasn’t resulted in financial commitments to fund further research.
Not even the first of two studies has been funded, according to the UN who says that about $58 million of the needed $100 million has been pledged. Shifting global health priorities and tight finances in the West are making it hard to raise funds for many worthy projects.
The most exciting aspect to the new AIDS treatment is its effectiveness in significantly reducing the onset of AIDS in women, when infected men refuse to wear a condom. via NYTimes
Experts say that the present cost of treating AIDS worldwide will cost $72 billion over the next four decades and rises to $225 billion if the infection continues on its current course.